HLA Knockout and Regenerative Medicine

This chapter explores the implications of HLA knockout techniques for improving immunogenicity in engineered cells for cancer treatment. It discusses the balance between short-term functionality and long-term viability of hypo immune stem cells, as well as the economic considerations of patient access to therapies. The speakers share insights into the benefits of patient-specific cells for treating diabetes, while also addressing challenges in immunosuppression and the necessity for high-quality production processes in regenerative medicine.